Main Menu
Community
Understand
Articles
Lymphoma and Pets
More
|
|
Lymphoma Information Network » Lymphoma Info » Chemotherapy - Vincristine
Chemotherapy - Vincristine
Brand Names: Oncovin, VCR, Vincasar Pfs
Vincristine is a chemotherapy drug that is administered for the treatment of acute leukemia, neuroblastoma, thyroid cancer, and lymphoma. It functions as an alkylating agent, meaning it prevents the replication of tumor cells by damaging the DNA.
The drug is used in the treatment of both Hodgkin and Non-Hodgkin's Lymphoma, and is administered in conjunction with other chemotherapy drugs in the following regimens:
- Stanford-V (adriamycin, mustargen, bleomycin, vinblastine, oncoving, etoposide, prednisone)
- BEACOPP (bleomycin, etoposide, adriamycin, cytoxan, oncovin, prednisone, procarbazine)
- CHOP (cytoxan, adriamycin, oncovin, prednisone)
- CHOP-R (CHOP + rituxan)
- MOPP (mustargen, oncovin, procarbazine, prednisone)
Drug Administration
Vincristine is given intravenously (IV). It is a vesicant, meaning it will irritate arteries, so it should be given through a vein only.
Side Effects
The most common side effect of vincristine use is hair loss. Less common side effects include low blood counts, constipation, nausea, abdominal pain, mouth sores, unusual bleeding and/or bruising, bone pain, and blood in the stool or urine.
SupportGroups.com builds awareness and support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Dive Deeper
Other Treatment Options
- Patients who are looking for more advanced treatment or who have lymphoma that does not respond to standard treatment may want to consider a clinical study. Click here to find clinical trials in your area.
- The Zevalin radioimmunotherapy regimen is now approved for certain types of NHL.
For more information on Hodgkin's disease, please see the following pages:
For more information on Non-Hodgkin Lymphoma, please see the following pages:

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
|
Cancer Support Groups
 SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Latest Questions and Answers
Latest Blog Entries
- Submitted by Angie on Tue, 11/17/2009 - 22:50
- Submitted by Ross on Tue, 11/10/2009 - 16:19
- Submitted by Ross on Mon, 11/09/2009 - 00:11
- Submitted by Ross on Mon, 11/09/2009 - 00:07
- Submitted by Ross on Sun, 11/08/2009 - 23:57
Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.
|
|